299 related articles for article (PubMed ID: 22202089)
1. Pathologic effects of RNase-L dysregulation in immunity and proliferative control.
Ezelle HJ; Hassel BA
Front Biosci (Schol Ed); 2012 Jan; 4(2):767-86. PubMed ID: 22202089
[TBL] [Abstract][Full Text] [Related]
2. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
3. An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.
Li XL; Ezelle HJ; Kang TJ; Zhang L; Shirey KA; Harro J; Hasday JD; Mohapatra SK; Crasta OR; Vogel SN; Cross AS; Hassel BA
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20816-21. PubMed ID: 19075243
[TBL] [Abstract][Full Text] [Related]
4. Diverse functions of RNase L and implications in pathology.
Bisbal C; Silverman RH
Biochimie; 2007; 89(6-7):789-98. PubMed ID: 17400356
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence.
Andersen JB; Mazan-Mamczarz K; Zhan M; Gorospe M; Hassel BA
RNA Biol; 2009; 6(3):305-15. PubMed ID: 19411840
[TBL] [Abstract][Full Text] [Related]
6. RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.
Brennan-Laun SE; Li XL; Ezelle HJ; Venkataraman T; Blackshear PJ; Wilson GM; Hassel BA
J Biol Chem; 2014 Nov; 289(48):33629-43. PubMed ID: 25301952
[TBL] [Abstract][Full Text] [Related]
7. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.
Brennan-Laun SE; Ezelle HJ; Li XL; Hassel BA
J Interferon Cytokine Res; 2014 Apr; 34(4):275-88. PubMed ID: 24697205
[TBL] [Abstract][Full Text] [Related]
8. New advances in our understanding of the "unique" RNase L in host pathogen interaction and immune signaling.
Gusho E; Baskar D; Banerjee S
Cytokine; 2020 Sep; 133():153847. PubMed ID: 27595182
[TBL] [Abstract][Full Text] [Related]
9. New insights into the role of RNase L in innate immunity.
Chakrabarti A; Jha BK; Silverman RH
J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus Controls Activation of the 2'-5'-Oligoadenylate Synthetase/RNase L Pathway Using at Least Two Distinct Mechanisms.
Sánchez-Tacuba L; Rojas M; Arias CF; López S
J Virol; 2015 Dec; 89(23):12145-53. PubMed ID: 26401041
[TBL] [Abstract][Full Text] [Related]
11. The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.
Ezelle HJ; Malathi K; Hassel BA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760998
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.
Lee TY; Ezelle HJ; Venkataraman T; Lapidus RG; Scheibner KA; Hassel BA
J Interferon Cytokine Res; 2013 Jan; 33(1):34-42. PubMed ID: 23113544
[TBL] [Abstract][Full Text] [Related]
13. RNase L and the NLRP3-inflammasome: An old merchant in a new trade.
Banerjee S
Cytokine Growth Factor Rev; 2016 Jun; 29():63-70. PubMed ID: 26987611
[TBL] [Abstract][Full Text] [Related]
14. A scientific journey through the 2-5A/RNase L system.
Silverman RH
Cytokine Growth Factor Rev; 2007; 18(5-6):381-8. PubMed ID: 17681844
[TBL] [Abstract][Full Text] [Related]
15. RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.
Malathi K; Siddiqui MA; Dayal S; Naji M; Ezelle HJ; Zeng C; Zhou A; Hassel BA
mBio; 2014 Oct; 5(6):e02012. PubMed ID: 25352621
[TBL] [Abstract][Full Text] [Related]
16. RNase L Cleavage Products Promote Switch from Autophagy to Apoptosis by Caspase-Mediated Cleavage of Beclin-1.
Siddiqui MA; Mukherjee S; Manivannan P; Malathi K
Int J Mol Sci; 2015 Jul; 16(8):17611-36. PubMed ID: 26263979
[TBL] [Abstract][Full Text] [Related]
17. RNase L targets distinct sites in influenza A virus RNAs.
Cooper DA; Banerjee S; Chakrabarti A; García-Sastre A; Hesselberth JR; Silverman RH; Barton DJ
J Virol; 2015 Mar; 89(5):2764-76. PubMed ID: 25540362
[TBL] [Abstract][Full Text] [Related]
18. The association of elevated 2',5'-oligoadenylate-dependent RNase L with lung cancer correlated with deficient enzymatic activity and decreased capacity of RNase L dimerization.
Yin H; Zhou A; Dai Y
Lung Cancer; 2012 Oct; 78(1):30-8. PubMed ID: 22925698
[TBL] [Abstract][Full Text] [Related]
19. Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs.
Cooper DA; Jha BK; Silverman RH; Hesselberth JR; Barton DJ
Nucleic Acids Res; 2014 Apr; 42(8):5202-16. PubMed ID: 24500209
[TBL] [Abstract][Full Text] [Related]
20. RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.
Malathi K; Saito T; Crochet N; Barton DJ; Gale M; Silverman RH
RNA; 2010 Nov; 16(11):2108-19. PubMed ID: 20833746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
